The Current Ratio as of December 2025 (TTM) for Iovance Biotherapeutics, Inc. (0JDK.L) is 3.27

According to Iovance Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.27. This represents a change of -15.08% compared to the average of 3.85 of the last 4 quarters.

Iovance Biotherapeutics, Inc. (0JDK.L) Historical Current Ratio (quarterly & annually)

How has 0JDK.L Current Ratio performed in the past?

The mean historical Current Ratio of Iovance Biotherapeutics, Inc. over the last ten years is 18.31. The current 3.27 Current Ratio has changed 1.69% with respect to the historical average. Over the past ten years (40 quarters), 0JDK.L's Current Ratio was at its highest in in the December 2015 quarter at 63.79. The Current Ratio was at its lowest in in the December 2023 quarter at 2.79.

Iovance Biotherapeutics, Inc. (0JDK.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Iovance Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Iovance Biotherapeutics, Inc. (0JDK.L) Average Current Ratio

How has 0JDK.L Current Ratio performed in the past?

The current Current Ratio of Iovance Biotherapeutics, Inc. (0JDK.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Iovance Biotherapeutics, Inc. (0JDK.L) Current Ratio vs. Peers

How is 0JDK.L’s Current Ratio compared to its peers?

Iovance Biotherapeutics, Inc.’s Current Ratio is less than Geron Corporation (5.96), less than Anavex Life Sciences Corp. (13.41), greater than Myriad Genetics, Inc. (1.42), greater than Esperion Therapeutics, Inc. (1.00), less than AxoGen, Inc. (4.09), less than Verastem, Inc. (3.46), less than Emergent BioSolutions Inc. (5.76), greater than Editas Medicine, Inc. (2.77), less than Nektar Therapeutics (4.24), greater than Sangamo Therapeutics, Inc. (1.05),

Build a custom stock screener for Iovance Biotherapeutics, Inc. (0JDK.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iovance Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Iovance Biotherapeutics, Inc. (0JDK.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Iovance Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.